39 completed, 11 unknown, 3 not yet recruiting, 3 recruiting. 61 Phase 3, 11 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 61 | Completed 39, Unknown 11, Not yet recruiting 3, Recruiting 3, Withdrawn 3, Terminated 2 |
| Phase 2 | 11 | Completed 4, Unknown 3, Recruiting 2, Not yet recruiting 1, Terminated 1 |
Follow Doxycycline: new trials by email Literature Review of Doxycycline trials Research Report on Doxycycline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women Doxycycline hyclate, Standard of Care for STI prevention - Sexually Transmitted Infection (STI), Gonorrhea | Phase 3 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 580 | 2026-11-30 | 2026-10-20 |
| AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis | Phase 3 | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 1794 | 2026-10-01 | 2026-08-27 |
| Rickettsia Clearance Study Doxycyclin, Azithromycin - Infectious Disease, Therapeutics | Phase 2 / Phase 3 | Recruiting | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | 72 | 2024-11-01 | 2026-10-13 |
| Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 100 | 2023-06-20 | 2023-06-12 |
| Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis Doxycycline, Placebo - Tuberculosis, Acute Coronary Syndrome | Phase 3 | Recruiting | National University Hospital, Singapore | 150 | 2023-05-24 | 2026-06-09 |
| Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer Metabolic treatment - Cancer, Overall Survival | Phase 3 | Withdrawn | Health Clinics Limited | 2022-05-23 | 2022-07-18 | |
| Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever Azithromycin + Doxycycline, Placebo + Doxycycline - Rocky Mountain Spotted Fever | Phase 3 | Unknown | Hospital General de Mexicali | 86 | 2022-05-12 | 2022-05-31 |
| A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) DFD-29, Doxycycline, Placebo - Papulopustular Rosacea | Phase 3 | Completed | Journey Medical Corporation | 330 | 2022-03-29 | 2024-12-03 |
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. DFD-29, Doxycycline, Placebo - Papulopustular Rosacea | Phase 3 | Completed | Journey Medical Corporation | 323 | 2022-03-14 | 2024-12-03 |
| Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional Voriconazole - Leishmaniasis, Cutaneous | Phase 3 | Unknown | Zagazig University | 136 | 2022-01-01 | 2023-08-29 |
| Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY) BPG, Doxycycline - Syphilis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 200 | 2021-12-06 | 2025-11-20 |
| Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps Doxycycline 100 mg Oral Tablet, Prednisolone 20 mg - Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Completed | Assiut University | 60 | 2021-07-01 | 2024-08-13 |
| DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19) Doxycycline, Placebo - COVID19 | Phase 3 | Withdrawn | Nantes University Hospital | 2021-02-01 | 2022-04-20 | |
| OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 " Doxycyclin - Covid19 | Phase 3 | Completed | Hedi Gharsallah | 194 | 2020-11-20 | 2021-11-19 |
| Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection Ivermectin and Doxycycline, Standard of care - Covid19 | Phase 3 | Completed | Dhaka Medical College | 400 | 2020-06-01 | 2020-10-09 |
| Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia HCQ, Azithromycin, Doxycycline - COVID 19, Patients Hospitalized | Phase 3 | Withdrawn | Abderrahmane Mami Hospital | 2020-05-15 | 2020-08-27 | |
| The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine, Clindamycin - CoVid 19 Positive | Phase 2 / Phase 3 | Completed | The Camelot Foundation | 1800 | 2020-04-11 | 2020-11-12 |
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2 / Phase 3 | Recruiting | The University of Queensland | 300 | 2020-03-02 | 2026-05-11 |
| Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI Doxycycline 100 MG Oral Tablet - Periprosthetic Infection, Oral Antibiotics | Phase 3 | Unknown | Rothman Institute Orthopaedics | 100 | 2019-09-24 | 2020-11-19 |
| Effect of Doxycycline on Cardiac Remodelling in STEMI Patients Doxycycline 100Mg Capsule, Placebo oral capsule - ST Elevation Myocardial Infarction, Anterior Wall Myocardial Infarction | Phase 3 | Unknown | Felix Chikita Fredy, MD | 80 | 2019-05-25 | 2019-08-06 |
Showing 20 of 61. Sign in to see all of them.
Acne Vulgaris (4) · COVID-19 (4) · Chlamydia Infections (4) · Rosacea (4) · Elephantiasis, Filarial (3) · Filariasis (3) · Lymphedema (3) · Syphilis (3) · Alzheimer Disease (2) · Chronic Periodontitis (2) · Disease (2) · Inflammation (2) · Lyme Disease (2) · Lyme Neuroborreliosis (2) · Neoplasm Metastasis (2)
National Institute of Allergy and Infectious Diseases (NIAID) (5) · The Task Force for Global Health (3) · CollaGenex Pharmaceuticals (2) · Fondazione IRCCS Policlinico San Matteo di Pavia (2) · Galderma R&D (2) · Journey Medical Corporation (2) · Nantes University Hospital (2) · Sorlandet Hospital HF (2) · Tanta University (2) · Abderrahmane Mami Hospital (1) · Amirhossein Farahmand (1) · Assistance Publique - Hôpitaux de Paris (1) · Assistance Publique Hopitaux De Marseille (1) · Assiut University (1) · CD Pharma India Pvt. Ltd. (1)
United States (20) · Canada (6) · United Kingdom (5) · Egypt (4) · France (4) · Germany (2) · India (2) · Italy (2) · Puerto Rico (2) · Singapore (2) · Tunisia (2) · Australia (1) · Bangladesh (1) · Botswana (1) · China (1)
Eric Ottesen, MD (3) · Srinivas R Sidgiddi, M.D. (2) · Alwin Cunje, MD, PhD (1) · Aly Ragaie (1) · Anne Marit Solheim, M.D (1) · Arun Sadasivan, MDS (1) · Arya K.S., BDS (1) · Bambang Widyantoro, PhD (1) · Batikh R Riadh, physican (1) · Brandon M Kucher, PhD (1) · Brandon M Kucher, PhD, MD (1) · Catherine Ong, MRCP PhD (1) · D.William Molloy, MB, MRCPI, FRCPC (1) · Dan Liang, MD (1)
PMID 11873261, PMID 22610930, PMID 32228663, PMID 10656038, PMID 40042869, PMID 17668979, PMID 17716312, PMID 17716313, PMID 18567539, PMID 18672990, PMID 20151804, PMID 20155838, PMID 20348487, PMID 20402591, PMID 20937388, PMID 21357860, PMID 21422479, PMID 21998287, PMID 22325113, PMID 22431798, PMID 23071896, PMID 23205917, PMID 23223595, PMID 23649042, PMID 24106340, PMID 24934963, PMID 25616607, PMID 26179246, PMID 26699167, PMID 31526286, PMID 32164673, PMID 32586344, PMID 32632956, PMID 33974018, PMID 33983065, PMID 37450935, PMID 38030064, PMID 38380975, PMID 38914204, PMID 39362220, PMID 41121745
2015 (1), 2019 (1), 2023 (1), R01AI072728 (1), R01AR043348 (1), R01DE012872 (1), R21AR053646 (1), U01HL128954 (1), U19AI031448 (1)